Joel O. Wertheim
- Virology top 0.2%
- HIV Research and Treatment 56
- Infectious Diseases top 0.5%
- HIV/AIDS Research and Interventions 45
- HIV/AIDS drug development and treatment 17
- SARS-CoV-2 and COVID-19 Research 10
- Modeling and Simulation top 1%
- Epidemiology top 2%
- HIV, Drug Use, Sexual Risk 29
- Hepatitis B Virus Studies 7
- Genetics top 2%
-
- Genomics and Phylogenetic Studies 15
-
- Hepatitis C virus research 10
- Co-authors
- Sergei L. Kosakovsky PondKonrad SchefflerBen MurrellDavey M. SmithThomas WeighillMichael WorobeySteven WeaverMartin D. Smith
- Partner nations
- United StatesUnited KingdomBelgium
In The Last Decade
Joel O. Wertheim
101 papers receiving 6.1k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Virology 1.6k
- Infectious Diseases 2.7k
- Modeling and Simulation 259
- Epidemiology 1.6k
- Genetics 1.1k
Countries citing papers authored by Joel O. Wertheim
This map shows the geographic impact of Joel O. Wertheim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel O. Wertheim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel O. Wertheim more than expected).
Fields of papers citing papers by Joel O. Wertheim
This network shows the impact of papers produced by Joel O. Wertheim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel O. Wertheim. The network helps show where Joel O. Wertheim may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Joel O. Wertheim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 5 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 5 | |
| 6 | 2022 | 20 | |
| 7 | 2021 | 105 | |
| 8 | 2021 | 10 | |
| 9 | 2021 | 6 | |
| 10 | 2020 | 23 | |
| 11 | 2020 | 214 | |
| 12 | 2020 | 5 | |
| 13 | 2019 | 26 | |
| 14 | 2019 | 25 | |
| 15 | 2018 | 29 | |
| 16 | 2017 | 2 | |
| 17 | 2017 | 46 | |
| 18 | 2017 | 17 | |
| 19 | 2016 | 34 | |
| 20 | 2016 | 49 |
About Joel O. Wertheim
Joel O. Wertheim is a scholar working on Virology, Infectious Diseases and Epidemiology, having authored 105 papers that have together received 6.2k indexed citations. Recurring topics across this work include HIV Research and Treatment (56 papers), HIV/AIDS Research and Interventions (45 papers), HIV, Drug Use, Sexual Risk (29 papers), HIV/AIDS drug development and treatment (17 papers), Genomics and Phylogenetic Studies (15 papers), SARS-CoV-2 and COVID-19 Research (10 papers), Hepatitis C virus research (10 papers) and Hepatitis B Virus Studies (7 papers). The work is most often cited by research in Virology (1.6k citations), Infectious Diseases (2.7k citations) and Modeling and Simulation (259 citations). Joel O. Wertheim has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Sergei L. Kosakovsky Pond, Konrad Scheffler, Ben Murrell, Davey M. Smith, Thomas Weighill, Michael Worobey, Steven Weaver, Martin D. Smith, Sanjay R. Mehta and Alexandra M. Oster. Their work appears in journals such as Science, Cell and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.